REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,091,043 | +14.2% | 2,242,636 | 0.0% | 14.51% | +24.7% |
| Q2 2023 | $23,727,089 | +7.5% | 2,242,636 | 0.0% | 11.64% | +26.5% |
| Q1 2023 | $22,067,538 | -33.1% | 2,242,636 | 0.0% | 9.20% | -33.4% |
| Q4 2022 | $32,989,176 | +21.3% | 2,242,636 | 0.0% | 13.80% | +33.2% |
| Q3 2022 | $27,203,000 | -13.3% | 2,242,636 | 0.0% | 10.36% | -21.7% |
| Q2 2022 | $31,374,000 | -1.8% | 2,242,636 | 0.0% | 13.24% | +21.3% |
| Q1 2022 | $31,935,000 | -32.5% | 2,242,636 | 0.0% | 10.92% | +6.8% |
| Q4 2021 | $47,297,000 | -19.6% | 2,242,636 | 0.0% | 10.22% | -25.1% |
| Q3 2021 | $58,847,000 | -16.9% | 2,242,636 | -1.3% | 13.64% | +3.6% |
| Q2 2021 | $70,815,000 | -11.4% | 2,271,177 | -12.8% | 13.16% | -14.7% |
| Q1 2021 | $79,889,000 | -22.5% | 2,603,089 | -13.3% | 15.43% | +5.9% |
| Q4 2020 | $103,029,000 | +11.5% | 3,003,772 | 0.0% | 14.58% | -15.4% |
| Q3 2020 | $92,426,000 | -0.8% | 3,003,772 | 0.0% | 17.24% | -37.8% |
| Q2 2020 | $93,177,000 | – | 3,003,772 | – | 27.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |